source
- Roche Diagnostics unveils single-assay newborn test for SMA, SCID and Sickle Cell DiseaseRoche Diagnostics introduced a new in‑vitro diagnostic kit called LightMix Newborn TREC/SMN1/HBB that can screen newborns for three rare genetic disorders in a single test. The assay simultaneousl…
- Foghorn Therapeutics cuts 40% of staff after Lilly partnership ends over weak phase-1 dataFoghorn Therapeutics announced it will lay off 40% of its workforce after its long‑standing collaboration with Eli Lilly fell apart due to disappointing phase‑1 trial results. The partnership, lau…